e-FabRIC

e-FabRIC is a leading European consortium dedicated to pioneering biotechnology research focused on combating new emerging infectious diseases with pandemic potential. With a strong emphasis on saving lives, e-FabRIC is at the forefront of developing innovative treatments that address new emerging viruses within the Sabercovirus family. The consortium is committed to demonstrating the potency of mosaic hyperimmunization and producing a multivalent polyclonal antibodies therapy.

e-FabRIC's comprehensive approach involves expert collaborators from esteemed institutions such as the University of Cambridge, the Institute of Tropical Medicine Antwerp, and the Foundation for Biomedical Research of the Hospital Universitario 12 De Octubre in Madrid, among others. This collaborative network enables e-FabRIC to leverage diverse expertise and resources in its mission to develop a broad-spectrum antiviral therapy. The company remains dedicated to fighting against emerging infectious diseases and advancing the field of biotechnology research.

e-FabRIC is driven by a vision of innovation and global health security. The company’s objectives are to advance scientific knowledge and provide effective solutions for emerging health threats. This information will be completed soon with the support of the company’s management.

To the manager of e-FabRIC, we invite you to create a customized and exclusive company showcase and product listing on our platform.